ReviewCancer immunology, immunotherapy : CII2026
Real-world efficacy and safety of immune checkpoint blockades in advanced urothelial carcinoma with histologic variant subtypes: the pembroblad study.
Karim Amrane et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.